Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013)

Vertex Pharmaceuticals' Convertible Debt history runs 4 years deep, the most recent figure standing at $400.0 million for Q1 2013.

• In Q1 2013, Convertible Debt changed 0.0% year-over-year to $400.0 million; the TTM figure through Mar 2013 stood at $400.0 million (changed 0.0% YoY), while the FY2012 annual figure was $400.0 million, changed 0.0% from the prior year.
• Convertible Debt for Q1 2013 stood at $400.0 million, roughly flat from $400.0 million in the prior quarter.
• The five-year high for Convertible Debt was $400.0 million in Q3 2010, with the low at $32.1 million in Q1 2010.
• The 4-year median for Convertible Debt is $400.0 million (2010), against an average of $366.6 million.
• Peak annual rise in Convertible Debt reached 1146.11% in 2011, while the deepest fall reached 0.0% in 2011.
• Vertex Pharmaceuticals' Convertible Debt stood at $400.0 million in 2010, then changed by 0.0% to $400.0 million in 2011, then changed by 0.0% to $400.0 million in 2012, then changed by 0.0% to $400.0 million in 2013.
• Business Quant data shows VRTX's Convertible Debt at $400.0 million in Q1 2013, $400.0 million in Q4 2012, and $400.0 million in Q3 2012.